COVID-19 Spreading Dynamics in an Age-Structured Population with Selective Relaxation of Restrictions for Vaccinated Individuals : a Mathematical Modeling Study

Author:

Shayak BORCID,Sharma Mohit MORCID,Mishra Anand K

Abstract

AbstractBackgroundCOVID-19 vaccination of healthcare and other essential workers is underway in many countries while immunization of the general public is expected to begin in the next several weeks. We consider the question of whether people who have received the vaccine can be selectively and immediately permitted to return to normal activities.MethodsWe use a delay differential equation model to calculate the effects of vaccinee “immunity passports” on the epidemic spreading trajectories. The model incorporates age-structuring to account for children who are ineligible for vaccination, and senior citizens who are especially vulnerable to the disease. We consider consensus strains of virus as well as high-transmissibility variants such as B1.1.7 and B1.351 in our analysis.ResultsWe find that with high vaccine efficacy of 80 percent or greater, unrestricted vaccinee—vaccinee interactions do not derail the epidemic from a path towards elimination. Vaccinee—non-vaccinee interactions should however be treated with far more caution. At current vaccine administration rates, it may be the better part of a year before COVID-19 transmission is significantly reduced or ceased. With lower vaccine efficacy of approximately 60 percent, restrictions for vaccinees may need to remain in place until the elimination of the disease is achieved. In all cases, the death tolls can be reduced by vaccinating the vulnerable population first.ConclusionsDesigning high-efficacy vaccines with easily scalable manufacturing and distribution capacity should remain on the priority list in academic as well as industrial circles. Performance of all vaccines should continue to be monitored in real time during vaccination drives with a view to analysing socio-demographic determinants of efficacy, if any, and optimizing distribution accordingly. A speedy and efficacious vaccination drive augmented with selective relaxations for vaccinees will provide the smoothest path out of the pandemic with the least additional caseloads, death tolls and socio-economic cost.

Publisher

Cold Spring Harbor Laboratory

Reference37 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

2. Baden LR , El Sahni HM , Essink B et. al., “Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine,” The New England Journal of Medicine (2021)

3. Voysey M , Clemens SAC , Madhi SA et. al., “Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 : an interim analysis of four randomized controlled trials in Brazil, South Africa and the UK,” The Lancet Infectious Diseases (2020)

4. Ella R , Mohan VK , Jogdand H et. al., “Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine BBC152 : a double-blind, randomized phase 1 trial” The Lancet Infectious Diseases (2021)

5. Ella R , Reddy S , Jogdand H et. al., “Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2 double-blind randomized controlled trial) and the persistence of immune responses from a phase 1 follow-up report,” MedRxiv Article (2020) available at https://www.medrxiv.org/content/10.1101/2020.12.21.20248643v1

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3